SG Americas Securities’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.87M Buy
32,212
+11,783
+58% +$640K ﹤0.01% 1431
2025
Q4
$943K Sell
20,429
-5,129
-20% -$229K ﹤0.01% 2069
2025
Q3
$921K Buy
25,558
+14,421
+129% +$478K ﹤0.01% 1542
2025
Q2
$362K Sell
11,137
-3,383
-23% -$111K ﹤0.01% 1876
2025
Q1
$548K Buy
14,520
+5,520
+61% +$441K ﹤0.01% 1701
2024
Q4
$737K Sell
9,000
-530
-6% -$52.6K ﹤0.01% 1036
2024
Q3
$1.09M Buy
9,530
+7,188
+307% +$648K ﹤0.01% 1022
2024
Q2
$177K Sell
2,342
-2,017
-46% -$137K ﹤0.01% 2233
2024
Q1
$298K Buy
+4,359
New +$302K ﹤0.01% 1695
2023
Q4
Sell
-27,980
Closed -$1.43M 3354
2023
Q3
$1.43M Buy
+27,980
New +$1.38M 0.02% 981
2023
Q2
Sell
-50,626
Closed -$1.9M 2960
2023
Q1
$1.9M Buy
50,626
+23,256
+85% +$986K 0.03% 697
2022
Q4
$1.31M Buy
27,370
+12,098
+79% +$475K 0.02% 796
2022
Q3
$367K Sell
15,272
-1,073
-7% -$27.2K 0.01% 1817
2022
Q2
$356K Buy
+16,345
New +$378K ﹤0.01% 2251
2022
Q1
Sell
-10,155
Closed -$242K 3326
2021
Q4
$242K Sell
10,155
-15,515
-60% -$361K ﹤0.01% 2568
2021
Q3
$651K Buy
+25,670
New +$622K ﹤0.01% 2278
2021
Q2
Sell
-6,714
Closed -$133K 3147
2021
Q1
$133K Buy
+6,714
New +$169K ﹤0.01% 2928

Other funds holding PCVX